This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Ashley Edward Fenwick: Innovator in Retroviral Protease Inhibitors
Introduction
Ashley Edward Fenwick is a notable inventor based in Radnor, PA (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target retroviral proteases. Her work is crucial in the fight against diseases caused by retroviral infections.
Latest Patents
Fenwick holds a patent for her invention titled "Retroviral protease inhibitors." This patent includes compounds, specifically dipeptide analogs, that bind to retroviral proteases. These compounds serve as inhibitors of retroviral proteases and are instrumental in treating diseases associated with retroviral infections. She has 1 patent to her name.
Career Highlights
Ashley Edward Fenwick is currently employed at SmithKline Beecham Corporation, where she continues her research and development efforts. Her work at the company has allowed her to focus on innovative solutions in the pharmaceutical industry.
Collaborations
Throughout her career, Fenwick has collaborated with esteemed colleagues, including Thomas Joseph Carr and Peter Lawrence DeMarsh. These partnerships have enhanced her research and contributed to the advancement of her projects.
Conclusion
Ashley Edward Fenwick is a pioneering inventor whose work on retroviral protease inhibitors has the potential to make a significant impact in the medical field. Her dedication to innovation continues to drive advancements in the treatment of retroviral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile